Sign In
Buy CHGCY
$23.16
-0.640 (-2.69%)
At Close: Jun 03, 2026
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q1 2026 Earnings Call Transcript
10:11am, Friday, 24'th Apr 2026
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q1 2026 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call Transcript
02:12pm, Thursday, 29'th Jan 2026
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript
02:58pm, Thursday, 24'th Jul 2025
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q2 2025 Earnings Conference Call July 24, 2025 4:00 AM ET Company Participants a - Corporate Participant Iwaaki Taniguchi - Executive VP, Head of Finance
Chugai Pharmaceutical Co. (CHGCY) Upgraded to Buy: Here's Why
01:00pm, Thursday, 24'th Apr 2025
Chugai Pharmaceutical Co. (CHGCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript
08:03am, Saturday, 01'st Feb 2025
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q4 2024 Earnings Conference Call January 30, 2025 3:30 AM ET Company Participants Kae Miyata - Head of Corporate Communications Department Osamu Okuda - R
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript
04:34pm, Friday, 25'th Oct 2024
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q3 2024 Earnings Conference Call October 25, 2024 5:00 AM ET Company Participants Kae Miyata - Corporate Communications Department Osamu Okuda - President
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript
08:42am, Saturday, 27'th Jul 2024
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q2 2024 Earnings Conference Call July 24, 2024 4:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and C
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:56am, Monday, 18'th Mar 2024
After losing some value lately, a hammer chart pattern has been formed for Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY), indicating that the stock has found support.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 06'th Mar 2024
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's Why
10:31am, Thursday, 12'th Oct 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) could be a great choice.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's What You Should Know
01:32pm, Thursday, 05'th Oct 2023
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
3 Stocks to Consider with Earnings Approaching
07:01pm, Friday, 21'st Apr 2023
As we progress through earnings season several top-rated Zacks stocks are expected to report their first quarter results on Monday, April 24.
